Balchem (BCPC)
(Delayed Data from NSDQ)
$170.55 USD
-1.48 (-0.86%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $170.43 -0.12 (-0.07%) 7:58 PM ET
4-Sell of 5 4
F Value C Growth B Momentum D VGM
Balance Sheet
Fiscal Year End for Balchem Corporation falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 64 | 67 | 103 | 85 | 66 |
Receivables | 125 | 132 | 117 | 98 | 93 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 110 | 120 | 91 | 71 | 84 |
Other Current Assets | 15 | 18 | 11 | 13 | 12 |
Total Current Assets | 314 | 336 | 322 | 267 | 255 |
Net Property & Equipment | 276 | 271 | 238 | 228 | 217 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 970 | 983 | 619 | 651 | 668 |
Deposits & Other Assets | 17 | 15 | 12 | 11 | 9 |
Total Assets | 1,597 | 1,625 | 1,199 | 1,166 | 1,156 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 56 | 57 | 56 | 24 | 37 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 58 | 53 | 63 | 49 | 36 |
Income Taxes Payable | 5 | 2 | 1 | 0 | 0 |
Other Current Liabilities | 26 | 23 | 21 | 19 | 17 |
Total Current Liabilities | 148 | 140 | 144 | 94 | 92 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 52 | 63 | 46 | 51 | 56 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 326 | 467 | 122 | 174 | 256 |
Non-Current Capital Leases | 2 | 2 | 2 | 0 | 0 |
Other Non-Current Liabilities | 0 | 0 | 3 | 12 | 2 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 543 | 686 | 322 | 338 | 412 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 2 | 2 | 2 | 2 | 2 |
Capital Surplus | 146 | 129 | 148 | 173 | 174 |
Retained Earnings | 897 | 814 | 732 | 657 | 591 |
Other Equity | 9 | -7 | -5 | 4 | -6 |
Treasury Stock | 0 | 0 | 0 | 8 | 18 |
Total Shareholder's Equity | 1,054 | 938 | 877 | 828 | 744 |
Total Liabilities & Shareholder's Equity | 1,597 | 1,625 | 1,199 | 1,166 | 1,156 |
Total Common Equity | 1,054 | 938 | 877 | 828 | 744 |
Shares Outstanding | 32.20 | 32.10 | 32.30 | 32.30 | 32.10 |
Book Value Per Share | 32.73 | 29.23 | 27.15 | 25.64 | 23.17 |
Fiscal Year End for Balchem Corporation falls in the month of December.
All items in Millions except Per Share data.
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 64 | 60 | 64 | 77 |
Receivables | NA | 123 | 140 | 125 | 129 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 117 | 110 | 110 | 116 |
Other Current Assets | NA | 16 | 14 | 15 | 19 |
Total Current Assets | NA | 320 | 325 | 314 | 341 |
Net Property & Equipment | NA | 273 | 274 | 276 | 269 |
Investments & Advances | NA | 0 | 0 | 0 | 0 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 946 | 954 | 970 | 959 |
Deposits & Other Assets | NA | 18 | 17 | 17 | 16 |
Total Assets | NA | 1,575 | 1,589 | 1,597 | 1,603 |
Liabilities & Shareholders Equity | 9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 55 | 60 | 56 | 50 |
Current Portion Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 51 | 49 | 58 | 54 |
Income Taxes Payable | NA | 3 | 12 | 5 | 0 |
Other Current Liabilities | NA | 0 | 0 | 26 | 0 |
Total Current Liabilities | NA | 113 | 124 | 148 | 108 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 50 | 51 | 52 | 59 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 284 | 319 | 326 | 396 |
Non-Current Capital Leases | NA | 2 | 2 | 2 | 2 |
Other Non-Current Liabilities | NA | 0 | 0 | 0 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 463 | 510 | 543 | 578 |
Shareholders Equity | 9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 2 | 2 | 2 | 2 |
Capital Surplus | NA | 159 | 154 | 146 | 141 |
Retained Earnings | NA | 959 | 926 | 897 | 896 |
Other Equity | NA | -7 | -4 | 9 | -14 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | 1,112 | 1,079 | 1,054 | 1,025 |
Total Liabilities & Shareholder's Equity | NA | 1,575 | 1,589 | 1,597 | 1,603 |
Total Common Equity | 0 | 1,112 | 1,079 | 1,054 | 1,025 |
Shares Outstanding | 32.40 | 32.40 | 32.40 | 32.20 | 32.20 |
Book Value Per Share | 0.00 | 34.33 | 33.30 | 32.73 | 31.84 |